CBOA
ONC

Commonwealth Bank of Australia’s BeOne Medicines Ltd ONC Stock Holding History

Commonwealth Bank of Australia’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$1K – 992
2019
Q2 		$1K Hold
10
– – ﹤0.01% 1143
2019
Q1 		$1K Sell
10
-22
-69% -$2.97K ﹤0.01% 1137
2018
Q4 		$4K Buy
32
+14
+78% +$1.86K ﹤0.01% 1124
2018
Q3 		$3K Buy
+18
New +$3.03K ﹤0.01% 1148

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Commonwealth Bank of Australia's ONC Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of BeOne Medicines Ltd (ONC) in Q3 2019, closing a stake of 10 shares — an estimated $1K sold.

Commonwealth Bank of Australia first reported a position in ONC in Q3 2018 and held it in 4 quarters. The position peaked at $4K in Q4 2018. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining BeOne Medicines Ltd position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 10 BeOne Medicines Ltd shares in Q3 2019, an estimated $1K.
  • Commonwealth Bank of Australia first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 4 quarters.
  • Commonwealth Bank of Australia's BeOne Medicines Ltd position peaked at $4K in Q4 2018.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.